A metro Atlanta manufacturer is investing millions in a South Georgia facility that's expected to create hundreds of jobs for ...

A vulnerability chain dubbed AutoJack in Microsoft's AutoGen Studio interface for prototyping AI agents could let attackers ...

Are standby generators worth the investment for homes in Amherst, NH, and the surrounding region? That question is explored in a HelloNation article ...

The FBI, Google, and Lumen Technologies say they’ve dismantled a China-based phishing-as-a-service operation called Outsider ...

ROAR OF A GENERATOR FILLS THE WORKOPSH AT THIS ELECTRICAL SUPPLY STORE IN RANCHO CORDOVA. THIS ONE WILL ACTUALLY AUTOMATICALLY START WHEN THE PORWE GOES OUT MANAGER RYAN HUGHSON SHOWS US WT'H’S IN ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Somerville company aims to ...